Is every six-week administration of natalizumab as extended interval dosing therapy appropriate…
- Resource Type
- Journal
- Language
- Japanese
- Region
- Japan
- Price
- $68.00
- Article Title
- Is every six-week administration of natalizumab as extended interval dosing therapy appropriate in Japanese patients with multiple sclerosis?
- Publication
- Neurology/脳神経内科
- ISSN
- 2434-3285
- Volume
- 90
- Issue
- 5
- Year
- 2019
- Pages
- 580-582
- Data Format
- Subject Fields
- Neurology
- Note
- Full text is usually delivered within 1-2 hours
